Latest Articles about NXTM

Covidien Issues STAR Trial Data - Analyst Blog

Zacks Equity Research — Sat, 09 Feb 2013 04:30:01 Z

International health care products major, Covidien plc. ( COV ) announced results of the two-year "Solitaire FR Thrombectomy for Acute Revascularization (STAR)" study. Results of

Covidien's 1Q Beats, Raises View - Analyst Blog

Zacks Equity Research — Sat, 26 Jan 2013 01:07:01 Z

Covidien plc. ( COV ) reported its adjusted earnings per share of $1.10 for the first quarter of fiscal 2013, 4 cents above the Zacks Consensus Estimate but 3 cents lower than the year-ago

LabCorp Remains at Neutral - Analyst Blog

Zacks Equity Research — Wed, 16 Jan 2013 00:30:01 Z

We have reaffirmed our Neutral recommendation on Laboratory Corporation of America Holdings ( LH ), the second largest independent clinical laboratory company in the U.S. This was primarily

Quest Diagnostics Remains at Neutral - Analyst Blog

Zacks Equity Research — Tue, 15 Jan 2013 23:13:37 Z

We recently reiterated our Neutral recommendation on Quest Diagnostics ( DGX ), the leading providers of commercial laboratory services in North America. While we hold a favorable view

Volcano Corporation Stays Neutral - Analyst Blog

Zacks Equity Research — Fri, 11 Jan 2013 20:50:01 Z

We have reaffirmed our Neutral recommendation on Volcano Corporation ( VOLC ) based on the company's disappointing third quarter 2012 and a sluggish prelim result for the fourth quarter

Casey Analyst Forecasts Explosive Biotech Growth

Trefis Team — Wed, 17 Oct 2012 21:31:09 Z

Submitted by The Life Sciences Report as part of our contributors program . This interview was conducted by The Life Sciences Report (10/11/12) The myth of technology, whether for

Why NxStage put trade may be bullish

David Russell — Mon, 14 May 2012 12:06:01 Z

One investor is using options to manage a trade in NxStage Medical. Our tracking systems detected the sale of 3,300 December 15 puts for about $1.52 against no previous open interest. He

Momentum Ideas: 6 Rallies Boosted by Hedge Funds and Short Seller Activity

Kapitall — Fri, 18 Nov 2011 04:37:33 Z

(Written by Alexander Crawford, list compiled by Eben Esterhuizen, CFA. Data from 11/14. Institutional data sourced from Fidelity, short data sourced from Yahoo! Finance, technical data sourced

Stocks Sitting in Modestly Negative Territory as Investors Decipher Economy's Direction

MidnightTrader.com Staff — Thu, 14 Oct 2010 20:25:34 Z

Stocks are in mostly negative territory at mid-day as investors tap back into a gloomy outlooking following disappointing economic data released this morning while interest rates on mortgages

Mid-Day Update: Stocks Give Up Some Prior-Session Gains On Discouraging Economic Data

MidnightTrader.com Staff — Thu, 14 Oct 2010 20:17:54 Z

Here's where markets stand at mid-day: -NYSE down 17.89 (-0.24%) to 7,543.61 -DJIA down 28.57 (-0.26%) to 11,067.51 -S&P 500 down 5.18 (-0.44%) to 1,172.92 -Nasdaq down 5.67